Among the other suggestions from the WHO, there was the proposed addition of a footnote into the Schedule I part of the Conference, stating that preparations containing predominantly cannabidiol and not a lot more than 0.2 for each cent of delta-9-tetrahydrocannabinol are not below Worldwide Manage.[35] Even so, the proposal was eventually rejected